Circulating Tumor Cells in Patients with Cholangiocarcinoma
About this study
The overall goal of this research is to measure the circulating tumor cell in the peripheral blood and investigate the association between circulating tumor cell level and tumor characteristics and prognosis.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Patients diagnosed with cholangiocarcinoma at Mayo Clinic Rochester
- Patients with a tumor size >5cm or CA19-9>1,000 or multifocal, or bilobar or metastatic disease
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.